Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04225611 · ClinicalTrials.gov registry record · Phase 1
Therapeutic Contact Lens Drug Delivery System (TCL-DDS) in Patients With Recurrent Cystoid Macular Edema
A Phase 1 study of Cystoid Macular Edema, sponsored by Massachusetts Eye and Ear Infirmary.
- Recruiting
- Registry status
- Phase 1
- Development phase
- 6
- Enrollment target
- 1
- Study location
NCT04225611 is a Phase 1 study of Cystoid Macular Edema that is actively recruiting participants, run by Massachusetts Eye and Ear Infirmary. The registered enrollment target is 6 participants. The trial reports 1 study location across 1 state.
The verdict
NCT04225611, a Phase 1 study of Cystoid Macular Edema, is actively recruiting participants, sponsored by Massachusetts Eye and Ear Infirmary.
- RECRUITING
- Registry status
- Phase 1
- Development phase
- 6 participants
- Enrollment target
- 1
- Study location
Study Summary
The main aim of the pilot study is to determine preliminary estimates of the safety, tolerability, and comfort of a dexamethasone-eluting therapeutic contact lens drug delivery system (TCL-DDS) for the treatment of recurrent cystoid macular edema. Secondarily, feasibility of the TCL-DDS system will be investigated. 1. Safety: To establish that a topical dexamethasone delivery system has an acceptable safety profile by determining the incidence and severity of ocular adverse events, as identified by eye examination through day 28 following treatment initiation. 2. Comfort and tolerability: to establish the subject tolerability and comfort of the TCL-DDS. 3. Feasibility: To establish- that a topical dexamethasone delivery system is a feasible treatment for recurrent cystoid macular edema.
Conditions Studied
Interventions
- DRUG Dexamethasone
Study Locations (1)
Massachusetts
- MEEI - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2021-03-15 |
| Est. Completion | 2027-12-31 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04225611
The ClinicalTrials.gov registry entry for NCT04225611 describes a study currently listed as recruiting, categorized as Phase 1. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts Eye and Ear Infirmary, which has 73 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Cystoid Macular Edema appearing as the primary indexed condition, and to 1 intervention - of which Dexamethasone is the first listed.
NCT04225611 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT04225611 about?
NCT04225611 is a clinical study titled "Therapeutic Contact Lens Drug Delivery System (TCL-DDS) in Patients With Recurrent Cystoid Macular Edema". The main aim of the pilot study is to determine preliminary estimates of the safety, tolerability, and comfort of a dexamethasone-eluting therapeutic contact lens drug delivery system (TCL-DDS) for the treatment of recurrent cystoid macular edema. Secondarily, feasibility of the TCL-DDS system will ...
What is the current status of trial NCT04225611?
This trial is currently recruiting. It is a Phase 1 study. The enrollment target is 6 participants. The study started on 2021-03-15. Estimated completion is 2027-12-31.
What conditions does trial NCT04225611 study?
This clinical trial studies the following conditions: Cystoid Macular Edema.
What interventions are being tested in trial NCT04225611?
The interventions under investigation include: Dexamethasone (DRUG).
Who is sponsoring clinical trial NCT04225611?
This trial is sponsored by Massachusetts Eye and Ear Infirmary, which has 73 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04225611 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cystoid Macular Edema
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.